Allied Market Research
Loading...
0
Upcoming Allied Market Research
2021
Peptide Therapeutics Market

Peptide Therapeutics Market: Global Opportunity Analysis and Industry Forecast, 2020–2027

A11226
Pages: NA
Dec 2021 | 299 Views
   
Author(s) : Onkar Sumant
Tables: NA
Charts: NA
  • Formats*:

  • SIngle User License, Five User
    License & Enterprise User License

  • Data Pack Excel License

  • IComes with the additional cost
    of $2500.00 contact sales.

 

COVID-19

Pandemic disrupted the entire world and affected many industries.

Get detailed COVID-19 impact analysis on the Peptide Therapeutics Market

Request Now !

Peptides represent a unique class of pharmaceutical compounds, molecularly with small molecules and proteins, but are biochemically and therapeutically distinct from both. The intrinsic signaling molecules for many physiological functions, peptides present an opportunity for therapeutic intervention that closely copies the natural pathways. There are several peptide drugs that essentially are the replacement therapies that add back or supplement peptide hormones in cases where endogenous levels are generally absent. The practice of isolating peptides from whole animal tissue with the purification of adrenocorticotrophic hormone (ACTH) from livestock pituitary glands can be used to treat a variety of endocrine disorders in patients. Peptides isolated from natural sources, such as the insulin ACTH, are provided as life-saving medicines.

Peptide-therapeutics

Market scope and structure analysis:

Report Metric

Details

  Market size available for years

  2020–2027

  Base year considered

  2019

  Forecast period

  2021–2027

  Forecast units

  Value (USD)

  Segments covered

Type, Application, Type of Manufacturer, Route of Administration, Synthesis Technology and Region

  Regions covered

North America (U.S. and Canada), Europe (Germany, UK, France, and the Rest of Europe), Asia-Pacific (China, Japan, India, and the Rest of Asia-Pacific), Latin America (Brazil, Mexico, and the Rest of LATAM) and The Middle East and Africa

  Companies covered

Major players analyzed include Eli Lilly and Company, Takeda Pharmaceutical Company Limited, Pfizer, Inc., Amgen, Inc., GlaxoSmithKline plc. (GSK), Teva Pharmaceuticals Industries Ltd., Lonza Inc., Bristol-Myers Squibb (BMS), AstraZeneca PLC, Sanofi, Novartis AG, and Novo Nordisk A/S

 

COVID-19 scenario analysis:

Pharmaceutical and biotech companies joined their hands with governments around the globe for working to address the COVID-19 outbreak, from supporting the research and development of vaccines to strategizing for medicines supply chain challenges. This led the key market players to focus on the R&D and hence gain maximum revenue when gets approval, currently 115 vaccine candidates and 155 molecules are in the pipeline. Hydroxychloroquine have witnessed dramatic surge in demand for the management of COVID-19 as the effectiveness of this drug is found to be useful than other drugs. Such high demand for these drugs has presented highest opportunity for the major manufacturers of COVID-19 management drugs. Due to the surge in the demand for vaccine and treatment drugs for COVID-19, the pharmaceutical and biotechnology industry is expected to experience a significant growth in the future.

Top impacting factors: Market Scenario Analysis, Trends, Drivers and Impact Analysis

The market is driven by rise in prevalence of cancer and various other metabolic disorders, which may either be genetically inherited or caused due to unhealthy lifestyle. The increase in investments on R&D of the drugs for therapeutics that are based on the segments such as diabetes, oncology segment, infectious disease and metabolic disorders would propel the industrial growth during the forecast period. The demand for cost-efficient drugs and surge in target population in the low-income countries is anticipated to help the market boost in the coming years. However, the lack of skilled professionals is anticipated to affect the peptide therapeutics market growth in the coming years.

Increase in funding for research and development to flourish the market

CARB-X is awarding Lytica Therapeutics, based in Cambridge, Massachusetts, USA, up to US$5.3 million in non-dilutive funding to develop antibacterial peptides with broad activity against multidrug-resistant bacteria.  The company could receive up to $11.6 million in additional funding if the project achieves certain development milestones, for a potential total of $16.9 million.

The CARB-X has chosen to fund the StAMP drug development program. StAMPs have shown the ability to treat highly drug resistant bacterial specimens. Through the support of CARB-X, it is expected that the development and working on the translation of the promising new therapeutic candidates will be carried out.

Surge in mergers and acquisitions to boost the market

In October 2019, Zealand Pharma A/S, a Copenhagen-based biotechnology company focused on the discovery and development of innovative peptide-based medicines, announced the acquisition of Encycle Therapeutics, Inc., a private Toronto-based biotech company exploiting a unique platform technology that enables the rapid synthesis of macrocyclic peptides exhibiting enhanced drug-like properties.

In May 2015, MorphoSys AG announced that it has acquired all outstanding shares of the Dutch biopharmaceutical company Lanthio Pharma B.V. The transaction brings Lanthio Pharma's lead compound LP2, a novel lanthipeptide in development for diabetic nephropathy and fibrotic diseases to MorphoSys's growing proprietary portfolio. LP2, which will be re-named MOR107, has demonstrated potent angiotensin II type 2 (AT2) receptor-dependent activity in vivo, and is planned to enter clinical trials in 2016. LP2 is the most advanced of four lanthipeptides in Lanthio Pharma's portfolio.

Key segments covered:

Segments

Sub-segments

  Type

  • Innovative
  • Generic

  Application

  • Cardiovascular Disorder
  • Respiratory
  • GIT
  • Anti-infection
  • Metabolic
  • Pain
  • Dermatology
  • CNS
  • Others

  Type of Manufacturer

  • Out-sourced
  • In-house

  Routes of Administration

  • Oral Route
  • Pulmonary
  • Parenteral Route
  • Mucosal
  • Others

  Synthesis Technology

  • Solid Phase Peptide Synthesis (SPPS)
  • Liquid Phase Peptide Synthesis (LPPS)
  • Hybrid Technology


Key benefits of the report:

  • This study presents the analytical depiction of the global peptide therapeutics industry along with the current trends and future estimations to determine the imminent investment pockets.
  • The report presents information related to key drivers, restraints, and opportunities along with detailed analysis of the global peptide therapeutics market share.
  • The current market is quantitatively analyzed from 2020 to 2027 to highlight the global Peptide Therapeutics market growth scenario.
  • Porter’s five forces analysis illustrates the potency of buyers & suppliers in the market.
  • The report provides a detailed global peptide therapeutics market analysis based on competitive intensity and how the competition will take shape in coming years.

Questions answered in the peptide therapeutics market research report:

  • Which are the leading market players active in the peptide therapeutics market?
  • What current trends will influence the market in the next few years?
  • What are the driving factors, restraints, and opportunities in the market?
  • What are the projections for the future that would help in tasking further strategic steps?
 
With collective industry experience of about 200 years of its analysts and experts, Allied Market Research (AMR) encompasses most infallible research methodology for its market intelligence and industry analysis. We do not only engrave the deepest levels of markets but also sneak through its slimmest details for the purpose of our market estimates and forecasts. Our approach helps in building greater market consensus view for size, shape and industry trends within each industry segment. We carefully factor in industry trends and real developments for identifying key growth factors and future course of the market. Our research proceeds are the resultant of high quality data, expert views and analysis and high value independent opinions. Our research process is designed to deliver balanced view of the global markets and allow stakeholders to make informed decisions.

We offer our clients exhaustive research and analysis based on wide variety of factual inputs, which largely include interviews with industry participants, reliable statistics and regional intelligence. Our in-house industry experts play instrumental role in designing analytic tools and models, tailored to the requirements of particular industry segment. These analytical tools and models sanitize the data & statistics and enhance the accuracy of our recommendations and advice. With AMR’s calibrated research process and 360` degree data-evaluation methodology, our clients are assured of receiving:

  • Consistent, valuable, robust and actionable data & analysis that can easily be referenced for strategic business planning
  • Technologically sophisticated and reliable insights through well audited and veracious research methodology
  • Sovereign research proceeds that present a tangible depiction of marketplace


With a strong methodology we are, therefore, confident that our research and analysis are most reliable and guarantees sound business planning.

Secondary research
We refer a broad array of industry sources for our secondary, which typically include; however, not limited to: Company SEC filings, annual reports, company websites, broker & financial reports and investor presentations for competitive scenario and shape of the industry

  • Patent and regulatory databases for understanding of technical & legal developments
  • Scientific and technical writings for product information and related preemptions
  • Regional government and statistical databases for macro analysis
  • Authentic new articles, web-casts and other related releases for market evaluation
  • Internal and external proprietary databases, key market indicators and relevant press releases for market estimates and forecast


Primary research
Our primary research efforts include reaching out participants through mail, tele-conversations, referrals, professional networks and face-to-face interactions. We are also in professional corporate relations with various companies that allow us greater flexibility for reaching out industry participants and commentators for interviews and discussions, fulfilling following functions:

  • Validates and improves the data quality and strengthens research proceeds
  • Further develops analyst team’s market understanding and expertise
  • Supplies authentic information about market size, share, growth and forecasts


Our primary research interview and discussion panels are typically composed of most experienced industry members. These participants include; however, not limited to:

  • Chief executives and VPs of leading corporations specific to industry
  • Product and sales managers or country heads; channel partners and top level distributors; banking, investments and valuation experts Key opinion leaders (KOLs)


Analyst tools and models
AMR has developed set of analyst tools and data models to supplement and expedite the analysis process. Corresponding to markets, where there is significant lack of information and estimates, AMR’s team of experts and analyst develop specific analyst tools and industry models to translate qualitative and quantitative industry indicators into exact industry estimates. These models also allow analysts to examine the prospects and opportunities prevailing in the market to accurately forecast the course of the market.
PURCHASE OPTIONS

Start reading ,This Report and over 13000+ thousand more Reports, Available with Avenue Library, T&C*

Call or Email us

U.S.-Canada
Toll-free :
+1-800-792-5285
Int'l : +1-503-894-6022
Europe : + 44-845-528-1300
Email : help@alliedmarketresearch.com
 
Allied Market Research Allied Market Research Allied Market Research

Access from any device, anywhere

Clients can easily download both quantitative as well as
qualitative reports in PDF and excel formats.

 

HAVE QUESTIONS?
SPEAK WITH ANALYST

 

FREQUENTLY ASKED
QUESTIONS?

 

DID YOU MISS ANYTHING?
DO YOU HAVE SPECIFIC REQUIREMENTS?

 

REQUEST TOC/SAMPLE

OR

Purchase Full Report of
Peptide Therapeutics Market

Start reading.
This Report and over 13,000+ thousand more Reports, Available with Avenue Library. T&C*.

  • Online Only
  • $3,456  $3,110
  • Online cloud access only
  • Restricted print, copy, paste & download
  • Read only
  •   Free quarterly industry update
  •   Free report update (Within 180 days)
  •   Subscription model sign in
  • Data Pack
  • $3,840  $3,456
  • Restricted to one authorized user
  • One print only
  • Available in
    Excel
  •   Free quarterly industry update
  •   Free report update (Within 180 days)
  •   Subscription model sign in
  • Single User
  • $5,769  $5,192
  • Restricted to one authorized user
  • One print only
  • Available in Excel & PDF
  •   Free quarterly industry update
  •   Free report update (Within 180 days)
  •   Subscription model sign in
  • Five Users
  • $6,450  $5,805
  • Limited to five authorized users
  • Print upto five copies
  • Available in Excel & PDF
  •   Free quarterly industry update
  •   Free report update (Within 180 days)
  •   Subscription model sign in
  • Enterprise
    License/PDF

  • $9,995  $8,996
  • Unlimited
    within
    company/enterprise
  • Available in Excel & PDF
  •   Free quarterly industry update
  •   Free report update (Within 180 days)
  •   Subscription model sign in
  • Library Membership
  • $ 699/mo
  • Published Content
    E-access
  • Company Profiles
    E-access
  • Newly Added Content Access
  • 10 PDF
    Downloads
  • 5 Excel Data
    Pack Downloads
  • 250 Company Profiles PDF Downloads
  • Buy Now

*Taxes/Fees, if applicable will be added during checkout. All prices in USD

 

Why Allied Market Research?

 

Infallible Methodology

To ensure high-level data integrity, accurate analysis, and impeccable forecasts

Analyst Support

For complete satisfaction

Customization

On-demand customization of scope of the report to exactly meet your needs

TARGETED MARKET VIEW

Targeted market view to provide pertinent information and save time of readers

 
 

Featured Reports

 

Erythropoietin Drugs Market

Global Opportunity Analysis and Industry Forecast, 2021–2028

Published in May 2021

Download Sample

Protein Therapeutics Market

Global Opportunity Analysis and Industry Forecast, 2017-2023

Published in Nov 2017

Download Sample

Surgical Equipment Market

Global Opportunity Analysis and Industry Forecast, 2020-2027

Published in Jan 2021

Download Sample

Medical Implant Market

Global Opportunity Analysis and Industry Forecast, 2020–2027

Published in Nov 2020

Download Sample

Featured Readings

 

Get fresh content delivered

Get insights on topics that are crucial for your business. Stay abreast of your interest areas.

 
Get Industry Data Alerts
 

Why Allied Market Research?

 

Infallible Methodology

To ensure high-level data integrity, accurate analysis, and impeccable forecasts

Analyst Support

For complete satisfaction

Customization

On-demand customization of scope of the report to exactly meet your needs

TARGETED MARKET VIEW

Targeted market view to provide pertinent information and save time of readers